Janssen Ad26.Mos4.HIV Vaccine — Vax-Before-Travel

Janssen Ad26.Mos4.HIV Vaccine

Fact checked by Robert Carlson, MD

Feb 3

4 min read

HIV Vaccine Candidate Fails in South Africa Study

Janssen prime and boost HIV vaccine strategy remains active phase 3 study

women in africa working

Sexually Transmitted Diseases

Fact checked by Robert Carlson, MD

Jan 2

4 min read

HIV-Associated Immune Amnesia Could Explain Why HIV-Positive People Have Shorter Lives

Immune amnesia could explain how people forget their immunity against illnesses

alarm clock and cup of coffee

Sexually Transmitted Diseases

Fact checked by Robert Carlson, MD

May 31

3 min read

HIV Preventive Vaccine Launches Large Phase 2b Efficacy Study

Imbokodo study is evaluating Ad26.Mos4.HIV and aluminum-phosphate adjuvanted Clade C gp 140 vaccine efficacy for the prevention of HIV

african women walknig carrying food on their head in baskets

Sexually Transmitted Diseases

Fact checked by Robert Carlson, MD

Jul 9

3 min read

HIV Vaccine Candidate Imbokodo Advances into Phase 2 Study

HVTN705 study is a Mosaic HIV vaccine candidate with the potential to protect people against a variety of HIV strains

medical lab tech

Sexually Transmitted Diseases